Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment

Anuradha Rebbapragada, Kathryn Howe, Charles Wachihi, Christopher Pettengell, Sherzana Sunderji, Sanja Huibner, T. Blake Ball, Francis A. Plummer, Walter Jaoko, Rupert Kaul

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Bacterial vaginosis (BV) has been associated with increased HIV cervicovaginal shedding. We hypothesized that this might relate to BV-associated increases in mucosal activated CD4+ T cells, which could enhance local HIV replication. Methods: Vaginal flora, cytokine/chemokine levels, and mucosal immune cell populations collected by cervical cytobrush were analyzed in 15 HIV-infected Kenyan female sex workers, before and after BV therapy with oral metronidazole. Results: Therapy reduced the Nugent score in all but 1 participant, and BV elimination was associated with reduced genital levels of interleukin 1β(IL1β), interleukin 8 (IL-8), and Regulated Upon Activation Normal T-cell Expressed and Secreted (RANTES). In addition, BV elimination reduced the total number of cervical CD4+ T cells, including those expressing the HIV coreceptor CCR5 and the activation marker CD69. Conclusions: BV induces significant and reversible alterations in cervical immune cell populations and local inflammatory cytokines that would be expected to enhance local HIV replication.

Original languageEnglish (US)
Pages (from-to)520-522
Number of pages3
JournalJournal of Acquired Immune Deficiency Syndromes
Volume49
Issue number5
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

Bacterial Vaginosis
HIV
T-Lymphocytes
Cytokines
Sex Workers
Metronidazole
Interleukin-8
Interleukin-1
Chemokines
Population
Therapeutics

Keywords

  • Altered vaginal flora
  • Bacterial vaginosis
  • Genital tract
  • HIV
  • Inflammation
  • Mucosal immunology
  • Transmission

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. / Rebbapragada, Anuradha; Howe, Kathryn; Wachihi, Charles; Pettengell, Christopher; Sunderji, Sherzana; Huibner, Sanja; Ball, T. Blake; Plummer, Francis A.; Jaoko, Walter; Kaul, Rupert.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 49, No. 5, 01.12.2008, p. 520-522.

Research output: Contribution to journalArticle

Rebbapragada, A, Howe, K, Wachihi, C, Pettengell, C, Sunderji, S, Huibner, S, Ball, TB, Plummer, FA, Jaoko, W & Kaul, R 2008, 'Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment', Journal of Acquired Immune Deficiency Syndromes, vol. 49, no. 5, pp. 520-522. https://doi.org/10.1097/QAI.0b013e318189a7ca
Rebbapragada, Anuradha ; Howe, Kathryn ; Wachihi, Charles ; Pettengell, Christopher ; Sunderji, Sherzana ; Huibner, Sanja ; Ball, T. Blake ; Plummer, Francis A. ; Jaoko, Walter ; Kaul, Rupert. / Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. In: Journal of Acquired Immune Deficiency Syndromes. 2008 ; Vol. 49, No. 5. pp. 520-522.
@article{80a0857606b24991bdc182c571310d61,
title = "Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment",
abstract = "Background: Bacterial vaginosis (BV) has been associated with increased HIV cervicovaginal shedding. We hypothesized that this might relate to BV-associated increases in mucosal activated CD4+ T cells, which could enhance local HIV replication. Methods: Vaginal flora, cytokine/chemokine levels, and mucosal immune cell populations collected by cervical cytobrush were analyzed in 15 HIV-infected Kenyan female sex workers, before and after BV therapy with oral metronidazole. Results: Therapy reduced the Nugent score in all but 1 participant, and BV elimination was associated with reduced genital levels of interleukin 1β(IL1β), interleukin 8 (IL-8), and Regulated Upon Activation Normal T-cell Expressed and Secreted (RANTES). In addition, BV elimination reduced the total number of cervical CD4+ T cells, including those expressing the HIV coreceptor CCR5 and the activation marker CD69. Conclusions: BV induces significant and reversible alterations in cervical immune cell populations and local inflammatory cytokines that would be expected to enhance local HIV replication.",
keywords = "Altered vaginal flora, Bacterial vaginosis, Genital tract, HIV, Inflammation, Mucosal immunology, Transmission",
author = "Anuradha Rebbapragada and Kathryn Howe and Charles Wachihi and Christopher Pettengell and Sherzana Sunderji and Sanja Huibner and Ball, {T. Blake} and Plummer, {Francis A.} and Walter Jaoko and Rupert Kaul",
year = "2008",
month = "12",
day = "1",
doi = "10.1097/QAI.0b013e318189a7ca",
language = "English (US)",
volume = "49",
pages = "520--522",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment

AU - Rebbapragada, Anuradha

AU - Howe, Kathryn

AU - Wachihi, Charles

AU - Pettengell, Christopher

AU - Sunderji, Sherzana

AU - Huibner, Sanja

AU - Ball, T. Blake

AU - Plummer, Francis A.

AU - Jaoko, Walter

AU - Kaul, Rupert

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Background: Bacterial vaginosis (BV) has been associated with increased HIV cervicovaginal shedding. We hypothesized that this might relate to BV-associated increases in mucosal activated CD4+ T cells, which could enhance local HIV replication. Methods: Vaginal flora, cytokine/chemokine levels, and mucosal immune cell populations collected by cervical cytobrush were analyzed in 15 HIV-infected Kenyan female sex workers, before and after BV therapy with oral metronidazole. Results: Therapy reduced the Nugent score in all but 1 participant, and BV elimination was associated with reduced genital levels of interleukin 1β(IL1β), interleukin 8 (IL-8), and Regulated Upon Activation Normal T-cell Expressed and Secreted (RANTES). In addition, BV elimination reduced the total number of cervical CD4+ T cells, including those expressing the HIV coreceptor CCR5 and the activation marker CD69. Conclusions: BV induces significant and reversible alterations in cervical immune cell populations and local inflammatory cytokines that would be expected to enhance local HIV replication.

AB - Background: Bacterial vaginosis (BV) has been associated with increased HIV cervicovaginal shedding. We hypothesized that this might relate to BV-associated increases in mucosal activated CD4+ T cells, which could enhance local HIV replication. Methods: Vaginal flora, cytokine/chemokine levels, and mucosal immune cell populations collected by cervical cytobrush were analyzed in 15 HIV-infected Kenyan female sex workers, before and after BV therapy with oral metronidazole. Results: Therapy reduced the Nugent score in all but 1 participant, and BV elimination was associated with reduced genital levels of interleukin 1β(IL1β), interleukin 8 (IL-8), and Regulated Upon Activation Normal T-cell Expressed and Secreted (RANTES). In addition, BV elimination reduced the total number of cervical CD4+ T cells, including those expressing the HIV coreceptor CCR5 and the activation marker CD69. Conclusions: BV induces significant and reversible alterations in cervical immune cell populations and local inflammatory cytokines that would be expected to enhance local HIV replication.

KW - Altered vaginal flora

KW - Bacterial vaginosis

KW - Genital tract

KW - HIV

KW - Inflammation

KW - Mucosal immunology

KW - Transmission

UR - http://www.scopus.com/inward/record.url?scp=62749093768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749093768&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e318189a7ca

DO - 10.1097/QAI.0b013e318189a7ca

M3 - Article

C2 - 18989228

AN - SCOPUS:62749093768

VL - 49

SP - 520

EP - 522

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 5

ER -